Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Other Working Capital Changes (2023 - 2025)

Historic Other Working Capital Changes for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to -$4.0 million.

  • Compass Therapeutics' Other Working Capital Changes fell 15433.27% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year decrease of 24928.25%. This contributed to the annual value of $4.9 million for FY2024, which is 17182.79% up from last year.
  • Per Compass Therapeutics' latest filing, its Other Working Capital Changes stood at -$4.0 million for Q3 2025, which was down 15433.27% from -$6.3 million recorded in Q2 2025.
  • Over the past 5 years, Compass Therapeutics' Other Working Capital Changes peaked at $5.5 million during Q1 2025, and registered a low of -$6.3 million during Q2 2025.
  • For the 3-year period, Compass Therapeutics' Other Working Capital Changes averaged around -$609909.1, with its median value being -$1.4 million (2023).
  • Data for Compass Therapeutics' Other Working Capital Changes shows a peak YoY increase of 48557.69% (in 2025) and a maximum YoY decrease of 22621.4% (in 2025) over the last 5 years.
  • Over the past 3 years, Compass Therapeutics' Other Working Capital Changes (Quarter) stood at -$1.5 million in 2023, then surged by 136.89% to $539000.0 in 2024, then tumbled by 846.01% to -$4.0 million in 2025.
  • Its last three reported values are -$4.0 million in Q3 2025, -$6.3 million for Q2 2025, and $5.5 million during Q1 2025.